Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
5(25%)
Results Posted
43%(3 trials)
Terminated
2(10%)

Phase Distribution

Ph early_phase_1
2
10%
Ph not_applicable
4
20%
Ph phase_1
1
5%
Ph phase_2
5
25%
Ph phase_4
5
25%
Ph phase_3
3
15%

Phase Distribution

3

Early Stage

5

Mid Stage

8

Late Stage

Phase Distribution20 total trials
Early Phase 1First-in-human
2(10.0%)
Phase 1Safety & dosage
1(5.0%)
Phase 2Efficacy & side effects
5(25.0%)
Phase 3Large-scale testing
3(15.0%)
Phase 4Post-market surveillance
5(25.0%)
N/ANon-phased studies
4(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

5

trials recruiting

Total Trials

20

all time

Status Distribution
Active(7)
Completed(7)
Terminated(2)
Other(4)

Detailed Status

Completed7
unknown4
Recruiting3
Not yet recruiting2
Active, not recruiting2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
20
Active
5
Success Rate
77.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (10.0%)
Phase 11 (5.0%)
Phase 25 (25.0%)
Phase 33 (15.0%)
Phase 45 (25.0%)
N/A4 (20.0%)

Trials by Status

completed735%
not_yet_recruiting210%
active_not_recruiting210%
terminated210%
recruiting315%
unknown420%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT07360379Not Applicable

Comparing N-Acetylcysteine (NAC) Versus Alpha-Lipoic Acid (ALA) as Adjuncts for Postoperative Pain Management After Laparoscopic Appendectomy

Not Yet Recruiting
NCT03451435Early Phase 1

N-Acetyl Cysteine Protects Pulpal Stem Cells in Endodontic Revascularization

Terminated
NCT05664789Phase 2

Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial

Recruiting
NCT07340944Not Applicable

Comparison of the Effects of N-acetylcysteine, Calcium Hydroxide, and Double Antibiotic Paste

Completed
NCT07229456Phase 3

Evaluation of the Role of N Acetyl Cysteine and Vitamin D in Improving Outcomes After Corrosive Ingestion

Active Not Recruiting
NCT06486805Phase 4

N-Acetyl Cysteine Effect on Liver Function After Mitral Valve Replacement

Completed
NCT04459052Phase 2

FDOPA PET and Nutritional Support in Parkinson's Disease

Active Not Recruiting
NCT05944458Phase 4

Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients

Completed
NCT07058090Phase 1

Comparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous Drugs for Tuberculosis at a Tertiary Care Hospital , Karachi

Not Yet Recruiting
NCT06484530Phase 4

Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis

Recruiting
NCT06297369Phase 2

Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients

Recruiting
NCT05927259Early Phase 1

The Role of N-acetylcysteine as a Novel Adjuvant Treatment in Acute Organophosphorus Pesticide Poisoning

Completed
NCT00967005Phase 2

N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers

Completed
NCT05738681Phase 2

Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial

Unknown
NCT05089981Not Applicable

Intravenous NAC Use in ACLF Patients

Unknown
NCT04756622Phase 3

N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation.

Unknown
NCT03680911Phase 3

NAC for Head Trauma-induced Anosmia

Terminated
NCT02541422Not Applicable

Use of NAC in Alleviation of Hangover Symptoms

Completed
NCT03440268Phase 4

Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement

Unknown
NCT01614431Phase 4

N Acetyl Cysteine for Cystinosis Patients

Completed

All 20 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
20